Trial ID or NCT#

NCT01631318

Status

not recruiting iconNOT RECRUITING

Purpose

Patients are invited to participate in a research study of liver perfusion (how blood flows to the liver over time). Researchers hope to learn whether perfusion characteristics of liver metastases may be predictive of response to treatment and whether liver perfusion characteristics can be used to follow response to treatment. Patients were selected as a possible participant in this study because they are identified as having liver metastases

Official Title

Pilot Technical Feasibility Study on 3D Contrast-enhanced Ultrasound Imaging and to Assess Whether Change in Ultrasound 3D Perfusion Pattern Can Predict Treatment Response

Eligibility Criteria

Ages Eligible for Study: Older than 18 Years
Sexes Eligible for Study: All
Accepts Healthy Volunteers: No

Investigator(s)

Aya Kamaya, MD
Aya Kamaya, MD
Radiologist
Professor of Radiology (Body Imaging)
George A. Fisher Jr.
George A. Fisher Jr.
Medical oncologist, Gastrointestinal specialist
Colleen Haas Chair in the School of Medicine
Amelie Lutz
Amelie Lutz
Diagnostic radiologist, Radiologist
Associate Professor of Radiology (Musculoskeletal Imaging)
Dimitre Hristov
Sanjiv Sam Gambhir, MD, PhD

Contact us to find out if this trial is right for you.

CONTACT

Risa Jiron
(650) 736-1598